Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-010569
Filing Date
2025-01-29
Accepted
2025-01-29 17:07:01
Documents
1
Period of Report
2025-01-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7240
  Complete submission text file 0000950170-25-010569.txt   8768
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Nguyen Diem (Reporting) CIK: 0001814338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38436 | Film No.: 25570246